MIT Scientists Develop Microfluidic Device to Screen Biologics for Quality During Production
Biologics, which are drugs made of biochemical compounds produced by living organisms, are becoming more common to treat a variety of conditions, including rheumatoid arthritis, chronic plaque psoriasis, and breast cancer. They’re usually prot...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Genetics Source Type: blogs
More News: Arthritis | Breast Cancer | Cancer | Cancer & Oncology | Chemistry | Genetics | Hormones | Medical Devices | Nanotechnology | Psoriasis | Rheumatoid Arthritis | Rheumatology | Study